It was early November. The Food and Drug Administration had just endured the high-profile, dramatic exit of its top drug ...
Investors riding a rare biotech recovery don’t need to jump off the train, but they should expect a bumpier ride. A mounting ...
The former officials say the agency's plan to revamp how vaccines for flu, Covid and other respiratory viruses are handled ...
Myocarditis is a known — but small — side effect of the mRNA Covid vaccines from Pfizer and Moderna, information that federal ...
The U.S. Food and Drug Administration warned people to stop using certain types of glucose monitor sensors that were linked ...
A large recall of shredded cheese sold under several brands is underway after the manufacturer reported the product may ...
The Exzolt Cattle-CA1 aka Fluralaner topical drug has received conditional approval from federal regulators to prevent and ...
The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...
THURSDAY, Dec. 4, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is facing even more leadership changes ...
People with diabetes depend on glucose readings to manage their care. Incorrect low readings can lead to excessive ...
The U.S. Food and Drug Administration has approved Axogen's nerve repair graft, the health regulator said on Wednesday, ...
MedPage Today on MSN
FDA Panel on Interatrial Shunt for Heart Failure: It's a Hard No
An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback